SMTL ID : 2aw2.3 (2 other biounits)

Crystal structure of the human BTLA-HVEM complex

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

hetero-2-2-mer

Ligands

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 2 residues within 4Å: Chain B: S.74, N.76 No protein-ligand interaction detected (PLIP)

1 x NI: NICKEL (II) ION(Non-covalent)

NI.2: 2 residues within 4Å: Chain A: H.114, H.116 2 PLIP interactions: 2 interactions with chain A Metal complexes: A:H.114, A:H.116

1 x NAG- FUL: beta-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-FUL.3: 2 residues within 4Å: Chain D: R.72, N.76 2 PLIP interactions: 2 interactions with chain D Hydrogen bonds: D:R.72, D:N.76

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Compaan, D.M. et al., Attenuating Lymphocyte Activity: the crystal structure of the BTLA-HVEM complex. J.Biol.Chem. (2005)

Release Date

2005-09-27

Peptides

B and T lymphocyte attenuator: AC
Tumor necrosis factor receptor superfamily member 14: BD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

C
X

B
B

D
Y

B and T lymphocyte attenuator

Tumor necrosis factor receptor superfamily member 14

Related Entries With Identical Sequence